Press Release: Enhabit Home Health & Hospice Announces Date of 2025 First Quarter Earnings Call

Dow Jones
18 Apr

Enhabit Home Health & Hospice Announces Date of 2025 First Quarter Earnings Call

DALLAS--(BUSINESS WIRE)--April 17, 2025-- 

Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2025, on May 7, 2025, and host a webcast and conference call on May 8, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

   -- May 8, 2025 
 
   -- 10 a.m. EDT 
 
   -- Toll-free: 888-660-6150 
 
   -- International: 929-203-0843 
 
   -- Conference ID: 5248158 
 
   -- Webcast link: https://events.q4inc.com/attendee/885393432 

A link to the webcast of the conference call and online replay can be found on Enhabit's investor website.

About Enhabit Home Health & Hospice

Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what's possible for patient care in the home. Enhabit's team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 255 home health locations and 115 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit enhabit.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250417290454/en/

 
    CONTACT:    Investor relations contact 

Jobie Williams

investorrelations@ehab.com

469-860-6061

Media contact

Erin Volbeda

media@ehab.com

972-338-5141

 
 

(END) Dow Jones Newswires

April 17, 2025 16:13 ET (20:13 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10